CompuGroup Medical Action: Neuer CEO sortt für Kurssprung – tecdax – Börsennachrichten

The CompuGroup Medical Aktie is listed at 15.62 Euro and has earned a German Anstieg of 5.67% in 52-Wochen-Tief. The prices are not below 181.97% below the 52-Wochen-Hoch. The most positive Entwicklung employee has during one of the following business activities: Prof. Dr. Daniel Gotthardt, chairman of the Unternehmensgründers, transferred to the function of CEO.

The market is reacting positively to the Führungswechsel

Daniel Gotthardt’s Ernennung is new to analysts when it comes to Schritt. If companies and software developers bring valuable expertise, the business niches of doctors, pharmacies and hospitals are responsible for their consolidation. Investors are now enjoying a trend change among eHealth specialists.

Proud of the young Kursgewin, the CompuGroup Medical Aktie will be made more attractive with a KGV of 8.7 for 2024 and a dividend of 3.62%. Separated for the further development of the Kursentwicklung, the new CEO is to further increase the Vertrust der Kunden zurückzugewinnen and the Wachstumsdynamik.

Display

CompuGroup Medical Action: Buy or sell?! Neue CompuGroup MedicalAnalyzevom 31. August loves the Antwort:

The noses of CompuGroup Medical-Zahlen speak a clear language: Urgent Long-term care request for CompuGroup Medical-Aktionäre. Do you want to make a purchase or another purchase? In the free analysis on August 31st it was time.

CompuGroup Medical: buy or sell? Read more here…